NF-κB was also reported to regulate MCL1 transcription downstream of the MEK/ERK signaling pathway upon sorafenib treatment in HCT116 cells [54]; however, it did not have a role in GC cells (Fig. S6B–S6D). The gene discussed is NFKB1; the disease is gastric cancer.